Recent blog posts
NCT07687784 Iron hydroxyethyl starch Anemia, Iron-Deficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07687784 Iron hydroxyethyl starch Anemia, Iron-Deficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07687784 clinical trial report covering Iron hydroxyethyl starch, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07686796 Sintilimab MSS/pMMR/MSI-L Rectal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07686796 Sintilimab MSS/pMMR/MSI-L Rectal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07686796 clinical trial report covering Sintilimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262597 SR-604 Hemophilia B Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262597 SR-604 Hemophilia B Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
CTR20262597 clinical trial report covering SR-604, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07689058 FACE-CAR T(Chinese Academy of Sciences) Relapse multiple myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07689058 FACE-CAR T(Chinese Academy of Sciences) Relapse multiple myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07689058 clinical trial report covering FACE-CAR T(Chinese Academy of Sciences), Phase 2, endpoints, sponsor, geography, readout timing and development whi
Read →
NCT07690059 SC-0032 Unexplained chronic cough Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07690059 SC-0032 Unexplained chronic cough Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07690059 clinical trial report covering SC-0032, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07690787 Albumin-Bound Paclitaxel Nasopharyngeal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07690787 Albumin-Bound Paclitaxel Nasopharyngeal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07690787 clinical trial report covering Albumin-Bound Paclitaxel, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07691333 Letrozole PIK3CA mutation/HR-positive/HER2-negative Breast Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07691333 Letrozole PIK3CA mutation/HR-positive/HER2-negative Breast Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07691333 clinical trial report covering Letrozole, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07689851 Retlirafusp alfa Recurrent Metastatic Gastric Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07689851 Retlirafusp alfa Recurrent Metastatic Gastric Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07689851 clinical trial report covering Retlirafusp alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07689162 Bupivacaine liposome Analgesia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07689162 Bupivacaine liposome Analgesia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07689162 clinical trial report covering Bupivacaine liposome, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07690826 HRS-4729 Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07690826 HRS-4729 Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07690826 clinical trial report covering HRS-4729, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07690371 Rezpegaldesleukin Moderate Atopic Dermatitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07690371 Rezpegaldesleukin Moderate Atopic Dermatitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07690371 clinical trial report covering Rezpegaldesleukin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07689292 Sacituzumab tirumotecan stomach adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07689292 Sacituzumab tirumotecan stomach adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07689292 clinical trial report covering Sacituzumab tirumotecan, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →